Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FYQAC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,798
Award facts
- Contract value 100% obligated
- $13,798.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $13,798.00 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contract portfolio focused on supplying pharmaceutical products and medical supplies to defense and veteran healthcare systems. The company's federal work encompasses delivery orders ranging from small-value transactions to substantial orders exceeding $45,000, covering a diverse range of medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The SPE2DX prime contract enables AmerisourceBergen to supply critical medical commodities to customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key vendor within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FYQAC?
SPE2DB25FYQAC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FYQAC worth?
The government has obligated $13,798 on SPE2DB25FYQAC.
Is contract SPE2DB25FYQAC an order under another contract?
Yes. SPE2DB25FYQAC is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYQAC competed?
The extent of competition for SPE2DB25FYQAC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award